Transactivation of gp130 in myeloma cells

Jena D. French, Denise K. Walters, Diane F. Jelinek

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Receptor transactivation, i.e., interaction between unrelated receptor systems, is a growing theme in cytokine and growth factor signaling. In this study we reveal for the first time the ability of IFN-α to transactivate gp130 in myeloma cells. An epidermal growth factor receptor/gp130 chimeric receptor previously shown by us to transactivate endogenous gp130, provided a complementary tool to study the underlying mechanisms of receptor cross-talk. Further analysis revealed that transactivation of gp130 by IFN-α did not require the extracellular or trans-membrane domain of gp130. Moreover, transactivation of gp130 was critically dependent upon Janus kinase activation by the initiating receptor and correlated with rapid and sustained Janus kinase 1 and tyrosine kinase (Tyk) 2 tyrosine phosphorylation. Finally, transactivation of gp130 may be a common theme in myeloma cells, perhaps providing a mechanism for enhanced or qualitatively distinct cellular responses to specific stimuli.

Original languageEnglish (US)
Pages (from-to)3717-3723
Number of pages7
JournalJournal of Immunology
Issue number7
StatePublished - Apr 1 2003

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Transactivation of gp130 in myeloma cells'. Together they form a unique fingerprint.

Cite this